Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2008
11/20/2008WO2008057171A3 4-1 bb ligand in inflammatory diseases
11/20/2008WO2008046107A3 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2008039716A3 Method for detecting il-16 activity and modulation of il-16 activity based on phosphorylated stat-6 proxy levels
11/20/2008WO2008013984A3 Compositions and methods for treating or preventing ophthalmic disease
11/20/2008WO2007130455A3 Compositions and methods for treatment of non-hodgkins lymphoma
11/20/2008WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease
11/20/2008WO2007115571A8 Erbb receptor-derived peptide fragments
11/20/2008WO2007087468A3 Adiponectin for treatment of various disorders
11/20/2008WO2007075414A3 Chemically derivatized cd4 and uses thereof
11/20/2008WO2005089527A3 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008WO2004030615A8 Compositions and methods for the diagnosis and treatment of tumor
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080287665 CANINE IgG NUCLEIC ACID MOLECULES
11/20/2008US20080287664 Hsp60 from arthrobacter
11/20/2008US20080287660 Derived from Xanthomonas campestris pv. campstris; for detecting or preventing a black-rot disease of a crucifer plant, making organic fertilizer or composting and being a biofilter for degradation of organic compounds
11/20/2008US20080287659 G-CSF Conjugates
11/20/2008US20080287657 Modified immunoglobulin receptor for use as enhanced indicator tool immunological detection; protein detection
11/20/2008US20080287656 Device and Method For Cell Free Analytical and Preparative Protein Synthesis
11/20/2008US20080287652 Antagonists Against Interaction of Pf4 and Rantes
11/20/2008US20080287651 Silk Thread Containing Spider Thread Protein and Silk Worm Producing the Silk Thread
11/20/2008US20080287650 High purity peptides
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection
11/20/2008US20080287361 Compositions and methods of using CRMP-1 and its fragments for treating cancer
11/20/2008US20080287358 Regulatory T Cell Mediator Proteins and Uses Thereof
11/20/2008US20080287357 Conjugate Comprising P21 Protein for the Treatment of Cancer
11/20/2008US20080287356 Chimeric Proteins, Their Preparation and Pharmaceutical Compositions Containing Them
11/20/2008US20080287354 Pure polypeptides, neural prosaposin receptor proteins; controlled release and liposome formulations; oral, topical, and injectable administration; Parkinson's and Alzheimer's Diseases, retinal neuropathy, amyotrophic lateral sclerosis
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287349 Fibroblast growth factor 20 and methods of use thereof
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080287346 Bioactive peptides
11/20/2008US20080287345 Polymyxin derivatives and uses thereof
11/20/2008US20080287342 Compositions Comprising Modified Collagen and Uses Therefor
11/20/2008US20080287311 Membrane-Translocating Peptides
11/20/2008US20080287310 Human Sweet and Umami Taste Receptor Variants
11/20/2008US20080287304 Mixture of at Least Two Fusion Proteins as Well as Their Production and Use
11/20/2008US20080286860 Cancer specific promoters
11/20/2008US20080286848 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
11/20/2008US20080286847 Inhibiting multimeric porphobilinogen synthase; for use as drug, toothpaste, soap, disinfectant, anti-biofilm and herbicide
11/20/2008US20080286836 Retroviral gene transfer element for enhancement of heterologous gene sequences in cells
11/20/2008US20080286834 Leader Sequences For Directing Secretion of Polypeptides and Methods For Production Thereof
11/20/2008US20080286828 Materials and methods relating to g-protein coupled receptor oligomers
11/20/2008US20080286824 System for Screening Cells for High Expression of a Protein of Interest (Poi)
11/20/2008US20080286821 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/20/2008US20080286817 Novel allergens and treatment
11/20/2008US20080286816 Detection of Methamphetamine Group Drugs
11/20/2008US20080286814 Biomarkers for Detecting Cancer
11/20/2008US20080286813 Antibody specific for mutant presenilin 1 and method of use thereof
11/20/2008US20080286806 Ligand for G-protein coupled receptor GPR43 and uses thereof
11/20/2008US20080286805 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
11/20/2008US20080286804 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
11/20/2008US20080286799 Methods of and kits and compositions for diagnosing colorectal tumors...
11/20/2008US20080286781 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/20/2008US20080286779 Host Cells Containing Multiple Integrating Vectors
11/20/2008US20080286770 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286756 Compositions and methods for diagnosing and treating severe acute respiratory syndrome (sars)
11/20/2008US20080286381 biodrug comprising a nucleic acid sequence of nucleic acid; anticarcinogenic agents or antitumor agents; including cisplatin and carboplatin; effective chemotherapeutic agents in efficiency, being less invasive or toxic, and increased rate of recovery
11/20/2008US20080286323 Human Therapeutic Cells Secreting Nerve Growth Factor
11/20/2008US20080286311 providing a wild-type protein allergen, splicing it into two parts that have a reduced allergenic activity or lacking allergenic activity and rejoining the two fragments in inverse orientation; allergy immunotherapy; low risk for anaphylactic shock; preparation of antiallergens
11/20/2008US20080286309 Portion of SpaA protein is deleted for protection from Erysipelothrix rhusiopathiae infection; genetic engineering; Porcine erysipelas; high purity
11/20/2008US20080286306 Plasmid DNA or viral vector vaccine including components from different clades of Env and Gag-Pol-Nef from a single clade; multiclade HIV envelope immunogen
11/20/2008US20080286303 Mutant Hin47 protein with decreased protease activity, and a high molecular weight protein of a strain of non-typeable Haemophilus influenzae; may be combined with diphtheria or tetanus toxoids, pertussis antigens or non-virulent poliovirus; immunization; otitis media
11/20/2008US20080286302 Two live mutant viruses of the same family containing a mutation in the viral genome at the same genomic site so the mutant viruses cannot recombine with each other to eliminate the mutations; Bovine viral diarrhea virus ; veterinary medicine
11/20/2008US20080286297 Chimeric Carrier Molecules for the Production of Mucosal Vaccines
11/20/2008US20080286295 Use of recombinant antigens to determine the immune status of an animal
11/20/2008US20080286294 Nodavirus-Vlp Immunization Composition
11/20/2008US20080286292 Molecular vaccine linking intercellular spreading protein to an antigen
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286285 Methods for Treating Vascular Disease
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication
11/20/2008US20080286269 Anti-alpha(v)beta(6) antibodies and uses thereof
11/20/2008US20080286248 Hiv Vif Mutants
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286239 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/20/2008US20080286229 Method to promote hair growth and/or delay or treat hair loss by administering a tgf-beta antagonist or inhibitor
11/20/2008CA2687715A1 Screening assay to identify correctors of protein trafficking defects
11/20/2008CA2687304A1 Signaling peptides
11/20/2008CA2686959A1 Methods for detecting cardiac damage
11/20/2008CA2686760A1 Labelled adrenomedullin derivatives and their use for imaging and therapy
11/20/2008CA2686216A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
11/20/2008CA2685769A1 Use of the augmenter of liver regeneration protein as an apoptosis regulator
11/20/2008CA2685551A1 Anti-tumor drug, medicament, composition, and use thereof
11/20/2008CA2671326A1 Methods of reversibly binding a biotin compound to a support
11/20/2008CA2670014A1 Production of anti-microbial peptides
11/20/2008CA2668208A1 Hybrid immunoglobulins with moving parts
11/20/2008CA2663249A1 Fluorescent proteins for monitoring intracellular superoxide production
11/19/2008EP1992697A1 Production of TNFR-Fc
11/19/2008EP1992696A1 Circovirus sequences associated with porcine wasting disease (PWD)